Aberrant localization of ezrin correlates with salivary acini disorganization in Sjögren’s Syndrome
Artículo
Open/ Download
Publication date
2010Metadata
Show full item record
Cómo citar
Pérez, Paola
Cómo citar
Aberrant localization of ezrin correlates with salivary acini disorganization in Sjögren’s Syndrome
Author
Abstract
Objectives. To analyse whether the alterations in the structure and organization of microvilli in salivary
acinar cells from SS patients are linked to changes in the expression and/or cellular localization of ezrin.
Methods. Salivary gland (SG) acini from controls and SS patients were used to evaluate ezrin expression
by western blot and localization of total and activated (phospho-Thr567) ezrin by IF and EM.
Results. In acini from control labial SGs, ezrin was located predominantly at the apical pole and to a
lesser extent at the basal region of these cells. Conversely, in acini extracts from SS patients, ezrin
showed significantly elevated levels, which were accompanied with localization mostly at the basal
region. Moreover, F-actin maintained its distribution in both the apical region and basolateral cortex;
however, it was also observed in the acinar cytoplasm. Phospho-ezrin (active form) was located exclusively
at the apical pole of acinar cells from control subjects and abundantly located at the basal
cytoplasm in SS samples. These results were confirmed by immunogold studies.
Conclusions. The decrease of ezrin and phospho-ezrin at the apical pole and the cytoplasmic redistribution
of F-actin suggest an altered interaction between the F-actin-cytoskeleton and plasma membrane
in SS patient acini, which may explain the microvilli disorganization. These alterations could eventually
contribute to SG hyposecretion in SS patients.
Patrocinador
Supported by grants (to M.-J.G., S.A. and C.M.)
FONDECYT-CHILE 1080006, 1050192. P.P. and M.B.
were supported by PhD fellowships granted by Conicyt,
Mecesup-Postgrade University of Chile 99-03.
Identifier
URI: https://repositorio.uchile.cl/handle/2250/128650
DOI: doi:10.1093/rheumatology/keq033
Quote Item
Rheumatology 2010;49:915–923
Collections